The National Diabetes Clinical Care Commission Act (H.R. 1192/S. 586), has been re-introduced in the 114th Congress by Representative Pete Olson (R-22nd-TX) and Representative Dave Loebsack (D-2-IA) in the House and Senator Jeanne Shaheen (D-NH) and Senator Susan Collins (R-ME), the Co-chairs of the Senate Diabetes Caucus, in the Senate. Carolinas-AACE Chapter members know that passage of this legislation is a high priority for AACE.
Members of the Carolinas Chapter-AACE are urged to go to the AACE Legislative Action Center to send an email to their federal lawmakers requesting co-sponsorship of H.R. 1192 and S. 586. AACE specifically requests that chapter members reach out to the offices of Senator Richard Burr (R-NC), Senator Thom Tillis (R-NC), Senator Lindsey Graham (R-SC) and Senator Tim Scott (R-SC) to request co-sponsorship of S. 586. The support of these senators representing the Carolinas Chapter will be critically important to move the legislation through the Senate in the 114th Congress.
AACE was joined by 45 national groups representing physicians, allied health professionals, patients, community health organizations and industry in sending a letter of support for the legislation to the House and Senate bill sponsors. AACE is proud that the entire diabetes community has again come together to support the legislation, including the American Diabetes Association, American Association of Diabetes Educators, Endocrine Society, JDRF, Pediatric Endocrine Society, and the Diabetes Advocacy Alliance. The re-introduced legislation also highlights the chronic diseases and conditions that are often complications of diabetes. Groups that have also recognized the value of this initiative and have endorsed the legislation include the American Academy of Family Physicians, American Podiatric Medical Association, American Society for Metabolic and Bariatric Surgery, American Society of Nephrology and The Obesity Society, among others. Additionally a number of our Corporate-AACE Partnership (CAP) members have endorsed the bill.
H.R. 1192/S. 586 establishes a new commission to evaluate federal diabetes activities and recommend new approaches to improve the quality of diabetes care. The Commission is intended to help the federal government address diabetes in a more effective, fiscally responsible manner by reviewing activities currently spread across more than 35 federal agencies and eliminating duplication, inconsistency, and identifying gaps in current diabetes efforts.
AACE advocacy on the National Diabetes Clinical Care Commission Act has also raised the profile and visibility of AACE on Capitol Hill as the organization representing diabetes experts and promoting a focus on diabetes in federal prevention and wellness activities and in chronic disease management.
Other federal diabetes legislation that AACE is supporting:
- Protecting Access to Diabetes Supplies Act of 2015 (H.R. 771) – This legislation enforces and strengthens provisions of the National Mail Order Program for Diabetic Testing Supplies that is part of Medicare’s Competitive Bidding Program. Specifically, the bill 1) requires suppliers to maintain and offer an adequate inventory of each of the types of testing supplies included in the supplier’s bid; and 2) prohibits contract suppliers from influencing or incentivizing patients to switch their current brand of glucose monitor and testing supplies to another brand, protecting patient access to preferred diabetes testing systems and supplies. The bill contains a number of other safeguards. Many of these issues were highlighted at the AACE/ACE Glucose Monitoring Consensus Conference in September, 2014.
- Medicare CGM Access Act of 2015 (H.R. 1497/ S. 804) – Legislation from the 113th Congress was re-introduced that would provide Medicare coverage for continuous glucose monitors (CGMs) to qualified beneficiaries. The current lack of Medicare coverage for CGMs is another issue that was highlighted at the AACE/ACE Glucose Monitoring Consensus Conference.
- Medicare Diabetes Prevention Act (S. 1131/H.R. 2102) - Introduced on April 29th, this legislation will provide Medicare coverage for qualified beneficiary enrollment in a national diabetes prevention program.
Top of page
|